MedTrace Logo

Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis

NCT01530438 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-04-09

No results posted yet for this study

Summary

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that involves not only motor structures, as was previously thought, but also brain areas dealing with cognition as well as parts of the limbic system. Clinical, imaging and pathological evidence suggests that ALS and fronto-temporal dementia (FTD) have several features in common, and that these two diseases could be the two ends of a pathological continuum.

Conditions

Interventions

OTHER

MRI + 18FDG-PET + neuropsychological assessments ; 18FDG performed especially for the research

At T0 and T9 or 12 monts, are performed : * Imaging : fMRI at rest and anatomical MRI * Neuropsychological assessments : general cognitive functioning, theory of mind, executive functions ...

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Laurence Carluer, MD · University Hospital, Caen

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2014-12-31
Completion
2015-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01530438 on ClinicalTrials.gov